Takeda Pharmaceutical Co. (TAK) vs Zoetis Inc. (ZTS)
- Takeda Pharmaceutical Co. TAK 19.67 +1.13%
- Zoetis Inc. ZTS 79.20 +0.99%
Takeda Pharmaceutical Co. and Zoetis Inc. are both Drug Manufacturers Specialty & Generic companies. Takeda Pharmaceutical Co. is the larger, with a market value of $61.9B against $32.4B — 1.9× the size. Zoetis Inc. trades at the lower P/E: 13.0× against 29.6×. Zoetis Inc. grew revenue faster over the last twelve months: 1.58% against 0.66%. Zoetis Inc. has the higher net margin (27.7% vs 7.12%) and the higher return on invested capital (19.6% vs 2.88%). Both pay a dividend; Zoetis Inc. yields more (2.64% vs 1.57%). Across the 23 metrics below, Zoetis Inc. leads on 16 and Takeda Pharmaceutical Co. on 7.
Valuation
Profitability
| Metric | TAK | ZTS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 65.85% | 71.67% | 53.94% |
| Operating margin | 11.61% | 37.13% | 0.00% |
| Net margin | 7.12% | 27.69% | 0.00% |
| Free cash flow margin | 24.74% | 24.43% | 0.00% |
| Return on equity | 4.42% | 64.91% | (0.40%) |
| Return on assets | 2.15% | 17.84% | (3.32%) |
| Return on invested capital | 2.88% | 19.60% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack